1. Report Industry Investment Rating No relevant content provided. 2. Core View of the Report - The report introduces commonly used Wind function modules and data in credit bond research, including primary and secondary market modules and relevant data processing methods [4]. 3. Summary by Directory 3.1 Wind Primary Market Module Introduction - **Querying Credit Bond Issuance and Maturity Details**: For non - financial credit bonds, select enterprise bonds, corporate bonds, medium - term notes, short - term financing bills, and private placement notes; for financial bonds, select financial bonds and deselect policy bank bonds. Conceptual sectors and enterprise nature can also be selected [11]. - **Querying Inter - bank Credit Bond Approval Progress**: Use the "Bond - Special Statistics - Primary Market - Issuance Registration - NAFMII Bond Registration Statistics - NAFMII Bond Registration Review Progress" path [12]. - **Querying Exchange Credit Bond Approval Progress**: Use the "Bond - Special Statistics - Primary Market - Issuance Registration - Corporate Bond Issuance Review Progress" and "Bond - Special Statistics - Primary Market - Issuance Registration - Enterprise Bond Issuance Review Progress" paths [13][14]. - **Statistical Credit Bond Raised Funds Usage**: Use the "Bond - Special Statistics - Credit Bond Raised Funds Allocation" path [15]. - **Finding Bonds Meeting Specific Conditions**: Use the "Bond - Multi - dimensional Data - Bond Screening" path and set conditional expressions [16]. 3.2 Wind Secondary Market Module Introduction - **Credit Bond Market Monitoring**: Use the "Bond - Bond Secondary Market - Transaction Statistics" path to display the most active bond information under the subject rating and remaining term [23][24]. - **Querying Credit Bond Inventory Details**: Use the "Bond - Market Overview - Inventory Statistics (by Bond Type)" path [25]. - **Distinguishing Broker Transactions and Platform Transactions**: Broker transactions involve brokers helping investors find trading counterparts, while platform transactions occur on CFETS or exchange platforms. Broker transaction data is suitable for constructing price indicators, and platform transaction data is suitable for constructing volume indicators [26][64]. - **Querying First - time Default Issuers**: Use the "Bond - Special Statistics - Credit Bond Research - Bond Default - Enterprise First - time Default Report" path and manually exclude issuers with previous default/extension situations [32][33]. - **Querying Default Bond Details**: Use the "Bond - Special Statistics - Credit Bond Research - Bond Default - Bond Default and Extension Summary" path and exclude duplicate bonds, exchangeable/convertible bonds, and cross - market bonds [34]. - **Exporting ChinaBond Index Market Performance**: Use the "Index - Index Analysis - Index Directory" path [36]. - **Constructing a Bond Portfolio**: Use the "Asset Management - Investment Research - Portfolio Management" path, including adjusting the starting cash amount and entering bond holdings and adjusting weights [37][38][39]. - **Tracking Bond Portfolio Performance**: Use the "Asset Management - Investment Research - Portfolio Management - Portfolio Report" path [40]. - **Conducting Attribution Analysis of Bond Portfolio Performance**: Use the "Asset Management - Investment Research - Portfolio Management - Performance Attribution" path [43]. 3.3 Credit Research Common Data Processing Methods - **Credit Bond Net Financing**: Export bond issuance and maturity details within a specific time range, divide bonds into industrial bonds and urban investment bonds based on the urban investment list, and calculate the net financing by subtracting the maturity amount from the issuance amount [49]. - **Credit Bond Primary Market Issuance Heat**: Refer to subscription multiples and the difference between coupon rate and bid - rate floor. Subscription multiples are calculated as the total bid (subscription) volume divided by the actual issuance amount, and bonds without relevant data should be excluded [50][54]. - **Credit Bond Issuance Approval Situation**: For urban investment bonds, refer to the completed registration scale and its proportion, and the number of feedbacks from the inter - bank market or exchange before listing [58]. - **Analyzing Credit Bond Valuation Distribution**: Export inventory credit bond details, match each urban investment bond to its corresponding province, divide the remaining exercise period into intervals, and use the SUMIFS function to calculate the weighted average valuation [59][60]. - **Observing Credit Bond Secondary Market Transactions**: Use both broker transaction data and platform transaction data. Broker transaction data is used for price indicators such as transaction deviation, transaction yield, and high - valuation transaction proportion; platform transaction data is used for volume indicators such as transaction term and turnover rate [64]. - **Volume Indicators**: Weighted transaction term is calculated based on platform data by excluding bonds with a remaining term of less than half a year and using transaction amount as the weight; transaction number is the sum of each bond's transaction numbers [65]. - **Price Indicators**: Transaction yield is calculated as the weighted average of transaction amounts; transaction deviation reflects the market's buying sentiment; high - valuation transaction proportion is the proportion of transactions with a yield 5bp higher than the valuation [71].

Report Industry Investment Rating No relevant content provided. Core Viewpoints - The intensity of anti-involution policies may be the biggest source of expectation divergence. In the short term, the bond market may remain weak, and the window for going long on bonds in the third quarter may be postponed. In the long term, anti-involution may help shorten the time required for a moderate recovery of inflation, and profound changes may be gradually occurring beneath the seemingly calm economic fundamentals [1][2][3]. - Compared with supply-side reform, the current anti-involution has a broader scope and can be seen as an upgraded version. It faces more complex supply-demand contradictions, a more challenging macro environment, and involves a wider range of industries [1][10]. - The market has different views on the ultimate intensity of anti-involution. Some investors believe that relying solely on supply-side anti-involution may not achieve policy goals due to weak demand, but it is unwise to underestimate the determination of the current anti-involution policies [2][18][19]. Summary by Directory 1. Fixed-income Perspective on the "Anti-involution Trading" Market - The anti-involution policy has driven the simultaneous rise of the equity and commodity markets, suppressing bond market sentiment and creating a seesaw effect between stocks/commodities and bonds. Understanding this policy is crucial for predicting the future bond market [10]. - The anti-involution policy has evolved from a framework to specific measures, triggering a "anti-involution trading" market in the commodity market. Compared with supply-side reform, anti-involution faces more complex supply-demand contradictions, a more challenging macro environment, and involves a wider range of industries [10][11][14]. - There are differences in investors' views on the ultimate intensity of anti-involution. Some think that the policy may fall short of expectations due to weak demand, but the current stage may just be the beginning of the policy implementation, and its intensity may exceed expectations. Moreover, demand-side issues should be viewed dialectically, and there is a possibility of positive feedback in the economy [2][18][19]. - In the short term, the bond market is likely to be influenced by the performance of the equity and commodity markets. The equity market has a bullish atmosphere, and the upcoming Sino-US-Sweden negotiations may boost the market. The commodity market may have a trend reversal, similar to the "924 market" in the equity market in 2024. The short-term bond market may be weak, and the window for going long may be postponed [3][22][23]. - In the long term, the impact of anti-involution on inflation needs further observation, but it may shorten the time for a moderate inflation recovery, and underlying changes may be taking place in the economic fundamentals [3][24].

Group 1 - Leshan Electric achieved operating revenue of 1.623 billion yuan, a year-on-year increase of 1.94%, and a net profit of 7.9031 million yuan, a year-on-year decrease of 14.55% [1] - Zhimingda reported operating revenue of 295 million yuan, a year-on-year increase of 84.83%, and a net profit of 38.3 million yuan, a year-on-year increase of 2147.93% [2] - Dahu Co. reported operating revenue of 426 million yuan, a year-on-year decrease of 14.40%, and a net loss of 2.5716 million yuan, an improvement from a loss of 13.7824 million yuan in the same period last year [3] - Yubang Electric expects a net profit of 21.2 million to 25 million yuan, a year-on-year decrease of 35.47% to 45.28% [4] - Zhejiang Securities achieved operating revenue of 6.512 billion yuan, a year-on-year decrease of 18.60%, and a net profit of 1.149 billion yuan, a year-on-year increase of 46.54% [5] - Huashu Media reported operating revenue of 4.435 billion yuan, a year-on-year increase of 2.07%, and a net profit of 254 million yuan, a year-on-year increase of 4.63% [7] Group 2 - Sinopec reported oil and gas equivalent production of 262.81 million barrels, a year-on-year increase of 2%, and crude oil processing volume of 119.97 million tons, a year-on-year decrease of 5.3% [8] - Hengrui Medicine's subsidiary received approval for clinical trials of HRS8179, aimed at reducing brain edema after stroke [8] - Hengrui Medicine's subsidiary also received approval for clinical trials of HRS-1893, intended for treating heart failure with preserved ejection fraction [8] - Wanfu Co. announced a plan to reduce its stake by up to 2% through block trading [10] - Biological Co. received a warning letter from the Inner Mongolia Securities Regulatory Bureau for inaccuracies in financial reporting [11] - Zhujiang Co. reported a signed construction area of 47.1432 million square meters across 396 projects [13] Group 3 - Watson Bio received a patent for a peptide delivery system for RNA drugs [15] - Sanwei Chemical signed 31 new contracts worth 335 million yuan in the second quarter [17] - Shenzhou Cell's SCT640C injection received approval for clinical trials for rheumatoid arthritis [18] - Xinjiang Jiaojian reported new contracts worth 1.434 billion yuan in the second quarter [19] - Lais Information plans to use 550 million yuan of idle funds for cash management [21] - Zhongqi New Materials signed a mining rights transfer contract, increasing production capacity [22] Group 4 - Hengtong Optic-Electric won multiple marine energy projects worth 1.509 billion yuan [24] - China State Construction signed new contracts totaling 2.501 trillion yuan in the first half of the year [26] - David Medical's ventilator product registration application has been accepted [28] - Tianhai Defense's subsidiary signed a construction contract worth 16.224 million yuan [29] - Nantian Information plans to sign a procurement framework contract worth 58.27 million yuan with its controlling shareholder [31] - Baida Group announced a plan to reduce its stake by up to 3% [32] Group 5 - Jinli Permanent Magnet plans to issue $117.5 million in convertible bonds [34] - Haizheng Pharmaceutical's fumarate bedaquiline raw material drug application has been approved [36] - Huatai passed the advanced intelligent factory re-evaluation in Anhui Province [37] - Everbright Bank's shareholder increased its stake from 7.08% to 8% [40] - Supor reported total operating revenue of 11.478 billion yuan, a year-on-year increase of 4.68%, and a net profit of 940 million yuan, a year-on-year decrease of 0.07% [41] - Qianjin Pharmaceutical's subsidiaries received registration certificates for two drugs [42]

证券代码：601878 证券简称：浙商证券 公告编号：2025-042 浙商证券股份有限公司 2025年半年度业绩快报公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 本公告所载2025年半年度主要财务数据为初步核算数据，未经会计师事务所 审计，具体数据以公司2025年半年度报告中披露的数据为准，提请投资者注意投 资风险。 一、2025年半年度主要财务数据和指标 单位：人民币元 | 项目 | 本报告期 | 上年同期 | 增减变动幅度（％） | | --- | --- | --- | --- | | 营业总收入 | 6,512,485,890.31 | 8,000,213,703.21 | -18.60 | | 营业利润 | 1,545,966,248.30 | 958,109,273.01 | 61.36 | | 利润总额 | 1,551,591,952.26 | 956,732,272.13 | 62.18 | | 归属于上市公司股东 | 1,149,413,823.33 | 784,352,341.09 | 46 ...

浙商证券(601878.SH)公告称，2025年上半年实现 营业收入65.12亿元，同比下降18.60%；实现归属于上 市公司股东的 净利润11.49亿元，同比增长46.54%。公司总 资产较上年末增长29.25%。 ...

Core Viewpoint - The article discusses the recent disclosure of public fund second-quarter reports by securities asset management firms, highlighting the growth in asset management scale and insights from fund managers [2][3]. Group 1: Asset Management Scale - As of the end of Q2 2025, four securities asset management firms have surpassed a public fund asset management scale of 100 billion yuan, with Dongfanghong Asset Management leading at 179.84 billion yuan, followed by Huatai Securities Asset Management at 165.11 billion yuan, and Zhongyin Securities at 130.31 billion yuan [4]. - Compared to the end of Q1 2025, the top securities asset management firms have generally experienced growth in public fund management scale, with Dongfanghong and Huatai Securities increasing by over 20 billion yuan each, and招商证券 growing by 3.3 billion yuan [4]. Group 2: Fund Manager Insights - The A-share market has been active in the first half of the year, with securities asset management fund managers generally reporting good performance and rising product net values [6]. - Jiang Qi, the fund manager of Dongfanghong Medical Upgrade Stock A, reported a net value increase of 44.55% in the first half of the year, reaching a new high since its inception [7]. - Jiang Qi maintains a high stock position of 90.37% and has increased allocations to innovative drugs in the Hong Kong and Sci-Tech Innovation Board markets, indicating a strong belief in the growth of the innovative drug sector [7]. - Zhou Yun, managing the Dongfanghong JD Big Data Mixed Fund, noted a net value increase of 6.55% in the first half of the year, emphasizing the long-term impact of low interest rates and the shift of household wealth towards equity assets [8]. - Jiang Cheng, Deputy General Manager of Zhongtai Asset Management, reported that his product's net value has increased over 108% in the past five years, while expressing a cautious outlook on individual stocks despite a generally optimistic macroeconomic view [9][10].

证券代码：601878 证券简称：浙商证券 公告编号：2025-041 本期发行短期融资券的相关文件已在以下网站上刊登： 1、中国货币网，http://www.chinamoney.com.cn； 2、上海清算所网站，http://www.shclearing.com。 特此公告。 浙商证券股份有限公司董事会 浙商证券股份有限公司 2025 年度第七期短期融资券发行结果公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 浙商证券股份有限公司 2025 年度第七期短期融资券已于 2025 年 7 月 21 日 发行完毕，相关发行情况如下： | 短期融资券名称 | 浙商证券股份有限公司 | 2025 年度第七期短期融资券 | | | --- | --- | --- | --- | | 短期融资券发行简称 | 25 浙商证券 CP007 | 短期融资券流通代码 | 072510131 | | 发行日 | 2025 年 7 月 18 日 | 起息日期 | 2025 年 7 月 21 日 | | 兑付日期 | 2025 年 12 ...

新浪期货 根据交易所数据，截至7月22日收盘主力合约工业硅2509,涨跌+5.98%,成交量123.44万手，持仓数据显示前20席位呈现净 空，差额头寸为46416手。 根据合并数据显示，多头前三席位为国泰君安期货，总持仓56716、中信期货，总持仓39984、中信建投，总持仓35498；空头前三 席位为国泰君安期货，总持仓55297、浙商期货，总持仓42775、永安期货，总持仓41654； 主力合约前20席位中，多头增仓前三名分别是：海通期货、持仓14386、增仓4116，中信建投、持仓21107、增仓1591，银河期 货、持仓13590、增仓813；多头减仓前三名分别是：中信期货、持仓22088、减仓-2983，国泰君安期货、持仓45744、减 仓-2085，东证期货、持仓12153、减仓-1884； 主力合约前20席位中，空头增仓前三名分别是：永安期货、持仓32168、增仓2044，浙商期货、持仓16192、增仓1498，一德期 货、持仓6924、增仓739；空头减仓前三名分别是：中信期货、持仓13608、减仓-1580，国泰君安期货、持仓38069、减仓-1569， 广州期货、持仓10062、减仓-5 ...

Core Points - The company, Hangzhou Oxygen Plant Group Co., Ltd., has received approval from the China Securities Regulatory Commission to publicly issue convertible bonds totaling 1.137 billion yuan with a term of six years [1][2][3] - The initial conversion price for the bonds is set at 28.69 yuan per share, which may be adjusted based on specific corporate actions such as stock dividends or capital increases [4][5][6] - The bonds will pay interest annually, with the first-year interest rate at 0.20% and the second-year rate at 0.40% [3][4] Bond Issuance Details - The total amount of the convertible bonds issued is 1.137 billion yuan, with each bond having a face value of 100 yuan [2][3] - The bonds will be issued on May 19, 2022, and will have a maturity period of six years [3] - Interest will be paid once a year, with the first payment occurring one year after the issuance date [4] Conversion and Redemption Terms - The conversion period for the bonds starts six months after issuance and lasts until the maturity date [4][5] - The company has the right to redeem the bonds at 108% of the face value plus the last interest payment within five business days after maturity [9] - Holders of the bonds can sell them back to the company at face value plus accrued interest if the stock price falls below 70% of the conversion price during the last two interest years [10][11] Use of Proceeds - The proceeds from the bond issuance will be used for specific projects, with a total investment of 1.38377 billion yuan, of which 1.137 billion yuan will be funded by the bond issuance [12][16] - Any shortfall in funding will be covered by the company through self-raised funds [12] Impact of Stock Buyback - The company plans to repurchase and cancel 5,539,375 shares of restricted stock due to unmet performance targets, which will affect the conversion price of the bonds [15][17] - The adjusted conversion price after the stock buyback will be 26.07 yuan per share, effective from July 21, 2025 [18][19]

Core Insights - The article discusses the recent developments in China's mother fund industry, highlighting a total management scale of 272.34 billion yuan, with investments focused on green low-carbon, marine economy, and high-end equipment manufacturing [1][2]. Group 1: Fund Establishments - Shandong: Three guiding funds, each with a scale of 10 billion yuan, were established in Qingdao [3][4]. - Jiangsu: A new industrial special fund with a scale of 155 billion yuan has been officially launched [7][17]. - Inner Mongolia: The first national-level sub-fund has been established with a scale of 1.6 billion yuan [18]. - Yunnan: The Yunnan Province Advanced Manufacturing Equity Investment Mother Fund has been set up with a scale of 50.08 million yuan [23][24]. - Guangdong: The Guangdong-Huizhou Industrial Investment Mother Fund has been established with a total scale of 1 billion yuan [25][26]. - Henan: The Jiyuan Industrial Mother Fund is set to be established [33]. - Shaanxi: The total scale of the Shaanxi Provincial Government Investment Guiding Fund has surpassed 100 billion yuan [34]. Group 2: Fund Characteristics and Focus Areas - Jiangsu's third batch of industrial special funds focuses on strategic emerging industries such as new energy, integrated circuits, and green technology [17][18]. - The national small and medium-sized enterprise development fund aims to support advanced manufacturing, information technology, and life sciences sectors [18]. - The Yunnan fund aims to enhance the competitiveness of the manufacturing sector and promote the development of strategic emerging industries [24]. - The Guangdong fund focuses on attracting key enterprises to enhance local economic development [26]. Group 3: Strategic Collaborations - Jiangsu's cooperation with China Chengtong Holdings Group aims to establish a 10 billion yuan fund to support technological innovation and industrial upgrades [19][22]. - The collaboration between Zhejiang Securities and the government of Huizhou City aims to deepen industry development and enhance investment efficiency [25][26]. - The establishment of the 明月湖科创基金丛林 in Chongqing aims to integrate innovation, industry, and capital to foster a new production capacity [37][38].